Laboratorios Farmaceuticos Rovi SA

41L

Company Profile

  • Business description

    Laboratorios Farmaceuticos Rovi SA is engaged in the production and sale of pharmaceutical products, including products developed in-house. Its activities include the sale of its own pharmaceutical products, the distribution of products under licences granted by other laboratories, and the provision of manufacturing services to third parties. Its operating segments are Manufacturing, which generates the maximum revenue from service contracts related to the finalisation of pharmaceutical product production processes for external entities and the manufacture of products to be marketed by other group companies, Marketing, and Other. It operates in Spain, the European Union, and other countries.

  • Contact

    Calle Julian Camarillo, 35
    Madrid28037
    ESP

    T: +34 913756230

    E: [email protected]

    https://www.rovi.es

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    2,470

Stocks News & Analysis

stocks

ASX tech share overvalued as growth path narrows

AI fears fade, growth risks remain.
stocks

Chart of the Week: ASX retail offers pockets of value in softening conditions

Why slowing consumer spending could create opportunities in overlooked retail stocks.
stocks

ASX tech share upgraded following AI contract wins

Strong demand for AI infrastructure drives fair value lift.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,794.40174.80-1.95%
CAC 407,851.21113.30-1.42%
DAX 4025,007.33191.86-0.76%
Dow JONES (US)50,702.56203.49-0.40%
FTSE 10010,430.86175.14-1.65%
HKSE24,613.2789.700.37%
NASDAQ26,874.9513.890.05%
Nikkei 22568,956.722,203.003.30%
NZX 50 Index13,810.5123.88-0.17%
S&P 5007,642.019.53-0.12%
S&P/ASX 2008,614.40174.90-1.99%
SSE Composite Index3,842.1911.740.31%

Market Movers